Effect of an Intranasal Corticosteroid in Young Children With Chronic Rhinosinusitis

This randomized clinical trial presents data about the clinical efficacy and changes in nasopharyngeal microbiome in children aged 4 to 8 years after treatment with intranasal mometasone furoate for chronic rhinosinusitis.
Source: JAMA Pediatrics - Category: Pediatrics Source Type: research